Healthcare professionals are involved in the detection, monitoring, management and treatment of chronic disease conditions such as diabetes. The American Diabetes Association (ADA) has stated that early detection is critical to improving disease outcomes. 

In early 2013 Freedom Meditech received FDA clearance for the first-in-class CLEARPATH DS-120 device that detects autofluorescence of the crystalline lens of the eye.  In independent scientific studies published in peer-reviewed journals, elevated autofluorescence measurements have been linked to high levels of advanced glycosylated end products, which accumulate in the presence of diabetes and uncontrolled glucose over time. 

Our market research indicates that the eye care provider is an ideal health professional to screen for diabetes:

  • Primary eye care providers experience more than two and half times the number of patient visits than the primary care provider (104 million vs. 40 million).

  • Most people with type 2 diabetes are within the ages of 35 and 55. This corresponds to the age when patients have frequent vision changes and are in need of glasses or lenses.
  • Optometry has a history of continuously enhancing their scope of practice, fulfilling the role of primary eye care provider.

If you would like to participate in our no-obligation clinical program, please contact us at 858-638-1433.

More Information Available for Download